n-vinyl-2-pyrrolidinone has been researched along with Neonatal Sepsis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Courtenay, AJ; Donnelly, RF; González-Vázquez, P; Jarrahian, C; Larrañeta, E; McCarthy, H; McCrudden, MTC; Quintanar-Solares, M; Rein-Weston, A; Zehrung, D | 1 |
1 other study(ies) available for n-vinyl-2-pyrrolidinone and Neonatal Sepsis
Article | Year |
---|---|
Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis.
Topics: Administration, Cutaneous; Animals; Animals, Newborn; Anti-Bacterial Agents; Drug Delivery Systems; Excipients; Female; Gentamicins; Humans; Kinetics; Mechanical Phenomena; Microinjections; Needles; Neonatal Sepsis; Permeability; Povidone; Rats, Sprague-Dawley; Skin; Solubility | 2017 |